Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives

被引:8
|
作者
Suzuki, Shinya [1 ]
Sugawara, Yuji [1 ]
Tsuji, Riichiro [1 ]
Tanimura, Ryuji [1 ]
Kaneko, Chihiro [1 ]
Yuzawa, Natsumi [1 ]
Yagi, Mai [1 ]
Kawai, Koji [1 ]
机构
[1] Toray Industries Ltd, Pharmaceut Res Labs, 6-10-1 Tebiro, Kamakura, Kanagawa 2488555, Japan
关键词
mu-Opioid receptor; kappa-Opioid receptor; Analgesic; Antipruritic; 4,5-Epoxymorphinan; TRK-820; DESIGN; ANTAGONISTS; MORPHINE;
D O I
10.1016/j.bmcl.2017.06.017
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
kappa-Opioid receptor agonists with high selectivity over the mu-opioid receptor are attractive targets in the development of drugs for pain and pruritus. We previously reported the synthesis of 10 alpha-hydroxy TRK-820 (1). In this study, we elucidated the biological properties of 1 and optimized its 6-acyl unit by modifying our synthetic route. Among the 10 alpha-hydroxy TRK-820 derivatives prepared, 26 showed the most potent kappa-opioid agonist activity (EC50= 0.00466 nM) and excellent selectivity and 22 was the most kappa-selective agonist. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3920 / 3924
页数:5
相关论文
共 50 条
  • [1] Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives (vol 27, pg 3920, 2017)
    Suzuki, Shinya
    Sugawara, Yuji
    Tsuji, Riichiro
    Tanimura, Ryuji
    Kaneko, Chihiro
    Yuzawa, Natsumi
    Yagi, Mai
    Kawai, Koji
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (03) : 515 - 515
  • [2] Syntheses of 10-oxo, 10α-hydroxy, and 10β-hydroxy derivatives of a potent κ-opioid receptor agonist, TRK-820
    Horikiri, H
    Hirano, N
    Tanaka, Y
    Oishi, J
    Hatakeyama, H
    Kawamura, K
    Nagase, H
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (06) : 664 - 669
  • [3] Antipruritic activity of the κ-opioid receptor agonist, TRK-820
    Togashi, Y
    Umeuchi, H
    Okano, K
    Ando, N
    Yoshizawa, Y
    Honda, T
    Kawamura, K
    Endoh, T
    Utsumi, J
    Kamei, J
    Tanaka, T
    Nagase, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 435 (2-3) : 259 - 264
  • [4] Effect of TRK-820, a selective kappa opioid receptor agonist, an rat schizophrenia model
    Yoshikawa, Satoru
    Ikeda, Ken
    Hareyama, Nana
    Kurokawa, Takahiro
    Nakao, Kaoru
    Mochizuki, Hidenori
    Ichinose, Hiroshi
    [J]. NEUROSCIENCE RESEARCH, 2008, 61 : S129 - S129
  • [5] Effects of TRK-820, a selective kappa opioid receptor agonist, on rat schizophrenia models
    Yoshikawa, Satoru
    Hareyama, Nana
    Ikeda, Ken
    Kurokawa, Takahiro
    Nakajima, Mayumi
    Nakao, Kaoru
    Mochizuki, Hidenori
    Ichinose, Hiroshi
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 606 (1-3) : 102 - 108
  • [6] Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonist
    Endoh, T
    Matsuura, H
    Tajima, A
    Izumimoto, N
    Tajima, C
    Suzuki, T
    Saitoh, A
    Suzuki, T
    Narita, M
    Tseng, L
    Nagase, H
    [J]. LIFE SCIENCES, 1999, 65 (16) : 1685 - 1694
  • [7] Syntheses of potential metabolites of a potent κ-opioid receptor agonist, TRK-820
    Kawamura, K
    Horikiri, H
    Hayakawa, J
    Seki, C
    Yoshizawa, K
    Umeuchi, H
    Nagase, H
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (06) : 670 - 674
  • [8] Pharmacological properties of TRK-820 on cloned μ-, δ- and κ-opioid receptors and nociceptin receptor
    Seki, T
    Awamura, S
    Kimura, C
    Ide, S
    Sakano, K
    Minami, M
    Nagase, H
    Satoh, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 376 (1-2) : 159 - 167
  • [9] The effects of TRK-820, a κ-opioid agonist, on neuropathic pain
    Hirakata, M
    Takasaki, I
    Suzuki, T
    Nakao, K
    Okano, K
    Tanaka, T
    Kuraishi, Y
    Nagase, H
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 89P - 89P
  • [10] TRK-820, a selective κ-opioid agonist, produces potent antinociception in cynomolgus monkeys
    Endoh, T
    Tajima, A
    Izumimoto, N
    Suzuki, T
    Saitoh, A
    Suzuki, T
    Narita, M
    Kamei, J
    Tseng, LF
    Mizoguchi, H
    Nagase, H
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 2001, 85 (03): : 282 - 290